ScinoPharm Taiwan Ltd
TWSE:1789

Watchlist Manager
ScinoPharm Taiwan Ltd Logo
ScinoPharm Taiwan Ltd
TWSE:1789
Watchlist
Price: 28.15 TWD -0.71% Market Closed
Updated: May 24, 2024

ScinoPharm Taiwan Ltd
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ScinoPharm Taiwan Ltd
Research & Development Peer Comparison

Comparables:
Y
3705
4746
S
4119
1795
1720

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
ScinoPharm Taiwan Ltd
TWSE:1789
Research & Development
-NT$357.7m
CAGR 3-Years
-13%
CAGR 5-Years
-3%
CAGR 10-Years
2%
Y
YungShin Global Holding Corp
TWSE:3705
Research & Development
-NT$314.1m
CAGR 3-Years
-1%
CAGR 5-Years
4%
CAGR 10-Years
1%
Formosa Laboratories Inc
TWSE:4746
Research & Development
-NT$824.7m
CAGR 3-Years
-16%
CAGR 5-Years
-13%
CAGR 10-Years
-16%
S
SCI Pharmtech Inc
TWSE:4119
Research & Development
-NT$49.1m
CAGR 3-Years
-4%
CAGR 5-Years
-6%
CAGR 10-Years
-4%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Research & Development
-NT$672.8m
CAGR 3-Years
-35%
CAGR 5-Years
-18%
CAGR 10-Years
-34%
Standard Chem & Pharm Co Ltd
TWSE:1720
Research & Development
-NT$268.1m
CAGR 3-Years
-16%
CAGR 5-Years
-4%
CAGR 10-Years
-1%

See Also

What is ScinoPharm Taiwan Ltd's Research & Development?
Research & Development
-357.7m TWD

Based on the financial report for Dec 31, 2023, ScinoPharm Taiwan Ltd's Research & Development amounts to -357.7m TWD.

What is ScinoPharm Taiwan Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
2%

Over the last year, the Research & Development growth was -32%. The average annual Research & Development growth rates for ScinoPharm Taiwan Ltd have been -13% over the past three years , -3% over the past five years , and 2% over the past ten years .